FDA Regulatory Advice

The pharmaceutical and biotechnology sectors in 2026 are operating under a new paradigm of rapid innovation and stringent oversight. In Tier 1 markets like the United States, United Kingdom, and Canada, the path from laboratory discovery to market availability is governed by complex FDA, MHRA, and Health Canada regulations. For biotech startups and established pharmaceutical…